• Something wrong with this record ?

Unfolded protein response markers Grp78 and eIF2alpha are upregulated with increasing alpha-synuclein levels in Lewy body disease

D. Hrabos, I. Poggiolini, L. Civitelli, E. Galli, C. Esapa, M. Saarma, P. Lindholm, L. Parkkinen

. 2024 ; 50 (4) : e12999. [pub] -

Language English Country England, Great Britain

Document type Journal Article

Persistent link   https://www.medvik.cz/link/bmc24019460

Grant support
PF-IMP-941400 Parkinson's Foundation
MH CZ-DRO (FNOl, 00098892) Ministry of Health, Czech Republic - conceptual development of research organization
IGA_LF_2024_010 Palacky University Olomouc
IGA_LF_2024_021 Palacky University Olomouc
G-1806 Parkinson's UK - United Kingdom
Weston Brain Institute
MJFF-019580 Michael J. Fox Foundation
NIHR Oxford Biomedical Research Centre

AIMS: Endoplasmic reticulum stress followed by the unfolded protein response is one of the cellular mechanisms contributing to the progression of α-synuclein pathology in Parkinson's disease and other Lewy body diseases. We aimed to investigate the activation of endoplasmic reticulum stress and its correlation with α-synuclein pathology in human post-mortem brain tissue. METHODS: We analysed brain tissue from 45 subjects-14 symptomatic patients with Lewy body disease, 19 subjects with incidental Lewy body disease, and 12 healthy controls. The analysed brain regions included the medulla, pons, midbrain, striatum, amygdala and entorhinal, temporal, frontal and occipital cortex. We analysed activation of endoplasmic reticulum stress via levels of the unfolded protein response-related proteins (Grp78, eIF2α) and endoplasmic reticulum stress-regulating neurotrophic factors (MANF, CDNF). RESULTS: We showed that regional levels of two endoplasmic reticulum-localised neurotrophic factors, MANF and CDNF, did not change in response to accumulating α-synuclein pathology. The concentration of MANF negatively correlated with age in specific regions. eIF2α was upregulated in the striatum of Lewy body disease patients and correlated with increased α-synuclein levels. We found the upregulation of chaperone Grp78 in the amygdala and nigral dopaminergic neurons of Lewy body disease patients. Grp78 levels in the amygdala strongly correlated with soluble α-synuclein levels. CONCLUSIONS: Our data suggest a strong but regionally specific change in Grp78 and eIF2α levels, which positively correlates with soluble α-synuclein levels. Additionally, MANF levels decreased in dopaminergic neurons in the substantia nigra. Our research suggests that endoplasmic reticulum stress activation is not associated with Lewy pathology but rather with soluble α-synuclein concentration and disease progression.

References provided by Crossref.org

000      
00000naa a2200000 a 4500
001      
bmc24019460
003      
CZ-PrNML
005      
20241024110808.0
007      
ta
008      
241015s2024 enk f 000 0|eng||
009      
AR
024    7_
$a 10.1111/nan.12999 $2 doi
035    __
$a (PubMed)39036837
040    __
$a ABA008 $b cze $d ABA008 $e AACR2
041    0_
$a eng
044    __
$a enk
100    1_
$a Hrabos, Dominik $u Nuffield Department of Clinical Neuroscience, University of Oxford, Oxford, UK $u Department of Clinical and Molecular Pathology, Palacky University Olomouc and University Hospital Olomouc, Olomouc, Czech Republic $u Department of Neurology, Palacky University Olomouc and University Hospital Olomouc, Olomouc, Czech Republic $1 https://orcid.org/0000000198560126
245    10
$a Unfolded protein response markers Grp78 and eIF2alpha are upregulated with increasing alpha-synuclein levels in Lewy body disease / $c D. Hrabos, I. Poggiolini, L. Civitelli, E. Galli, C. Esapa, M. Saarma, P. Lindholm, L. Parkkinen
520    9_
$a AIMS: Endoplasmic reticulum stress followed by the unfolded protein response is one of the cellular mechanisms contributing to the progression of α-synuclein pathology in Parkinson's disease and other Lewy body diseases. We aimed to investigate the activation of endoplasmic reticulum stress and its correlation with α-synuclein pathology in human post-mortem brain tissue. METHODS: We analysed brain tissue from 45 subjects-14 symptomatic patients with Lewy body disease, 19 subjects with incidental Lewy body disease, and 12 healthy controls. The analysed brain regions included the medulla, pons, midbrain, striatum, amygdala and entorhinal, temporal, frontal and occipital cortex. We analysed activation of endoplasmic reticulum stress via levels of the unfolded protein response-related proteins (Grp78, eIF2α) and endoplasmic reticulum stress-regulating neurotrophic factors (MANF, CDNF). RESULTS: We showed that regional levels of two endoplasmic reticulum-localised neurotrophic factors, MANF and CDNF, did not change in response to accumulating α-synuclein pathology. The concentration of MANF negatively correlated with age in specific regions. eIF2α was upregulated in the striatum of Lewy body disease patients and correlated with increased α-synuclein levels. We found the upregulation of chaperone Grp78 in the amygdala and nigral dopaminergic neurons of Lewy body disease patients. Grp78 levels in the amygdala strongly correlated with soluble α-synuclein levels. CONCLUSIONS: Our data suggest a strong but regionally specific change in Grp78 and eIF2α levels, which positively correlates with soluble α-synuclein levels. Additionally, MANF levels decreased in dopaminergic neurons in the substantia nigra. Our research suggests that endoplasmic reticulum stress activation is not associated with Lewy pathology but rather with soluble α-synuclein concentration and disease progression.
650    _2
$a senioři $7 D000368
650    _2
$a senioři nad 80 let $7 D000369
650    _2
$a ženské pohlaví $7 D005260
650    _2
$a lidé $7 D006801
650    _2
$a mužské pohlaví $7 D008297
650    _2
$a lidé středního věku $7 D008875
650    12
$a alfa-synuklein $x metabolismus $7 D051844
650    _2
$a biologické markery $x metabolismus $7 D015415
650    _2
$a mozek $x metabolismus $x patologie $7 D001921
650    12
$a chaperon endoplazmatického retikula BiP $x metabolismus $7 D000091342
650    _2
$a stres endoplazmatického retikula $x fyziologie $7 D059865
650    12
$a eukaryotický iniciační faktor 2 $x metabolismus $7 D015852
650    12
$a proteiny teplotního šoku $x metabolismus $7 D006360
650    12
$a demence s Lewyho tělísky $x patologie $x metabolismus $7 D020961
650    _2
$a neurotrofní faktory $x metabolismus $7 D009414
650    12
$a signální dráha UPR $x fyziologie $7 D056811
650    12
$a upregulace $7 D015854
655    _2
$a časopisecké články $7 D016428
700    1_
$a Poggiolini, Ilaria $u Nuffield Department of Clinical Neuroscience, University of Oxford, Oxford, UK
700    1_
$a Civitelli, Livia $u Nuffield Department of Clinical Neuroscience, University of Oxford, Oxford, UK
700    1_
$a Galli, Emilia $u Institute of Biotechnology, Helsinki Institute of Life Science, University of Helsinki, Helsinki, Finland
700    1_
$a Esapa, Chris $u Mammalian Genetics Unit, MRC Harwell Institute, Harwell Science and Innovation Campus, Didcot, UK
700    1_
$a Saarma, Mart $u Institute of Biotechnology, Helsinki Institute of Life Science, University of Helsinki, Helsinki, Finland
700    1_
$a Lindholm, Päivi $u Institute of Biotechnology, Helsinki Institute of Life Science, University of Helsinki, Helsinki, Finland
700    1_
$a Parkkinen, Laura $u Nuffield Department of Clinical Neuroscience, University of Oxford, Oxford, UK $1 https://orcid.org/0000000233928564
773    0_
$w MED00003495 $t Neuropathology and applied neurobiology $x 1365-2990 $g Roč. 50, č. 4 (2024), s. e12999
856    41
$u https://pubmed.ncbi.nlm.nih.gov/39036837 $y Pubmed
910    __
$a ABA008 $b sig $c sign $y - $z 0
990    __
$a 20241015 $b ABA008
991    __
$a 20241024110802 $b ABA008
999    __
$a ok $b bmc $g 2201978 $s 1231433
BAS    __
$a 3
BAS    __
$a PreBMC-MEDLINE
BMC    __
$a 2024 $b 50 $c 4 $d e12999 $e - $i 1365-2990 $m Neuropathology and applied neurobiology $n Neuropathol Appl Neurobiol $x MED00003495
GRA    __
$a PF-IMP-941400 $p Parkinson's Foundation
GRA    __
$a MH CZ-DRO (FNOl, 00098892) $p Ministry of Health, Czech Republic - conceptual development of research organization
GRA    __
$a IGA_LF_2024_010 $p Palacky University Olomouc
GRA    __
$a IGA_LF_2024_021 $p Palacky University Olomouc
GRA    __
$a G-1806 $p Parkinson's UK $2 United Kingdom
GRA    __
$p Weston Brain Institute
GRA    __
$a MJFF-019580 $p Michael J. Fox Foundation
GRA    __
$p NIHR Oxford Biomedical Research Centre
LZP    __
$a Pubmed-20241015

Find record

Citation metrics

Archiving options